Hooper v. State

106 S.W.3d 270, 2003 WL 1922371
CourtCourt of Appeals of Texas
DecidedMay 22, 2003
Docket03-02-00354-CR
StatusPublished
Cited by11 cases

This text of 106 S.W.3d 270 (Hooper v. State) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hooper v. State, 106 S.W.3d 270, 2003 WL 1922371 (Tex. Ct. App. 2003).

Opinion

OPINION

W. KENNETH LAW, Chief Justice.

Appellant Jack Elwood Hooper appeals his conviction for possession of a controlled-substance analogue of more than four hundred grams. See Tex. Health & Safety Code Ann. § 481.123(b)(2) (West Supp.2003). In a bench trial, the trial court found appellant guilty of the offense charged. Appellant “entered a plea of true” to the enhancement paragraph of the indictment alleging a prior felony theft conviction. The trial court assessed appellant’s punishment at fifteen years’ imprisonment. We will affirm the trial court’s judgment.

BACKGROUND

Appellant was originally indicted for this offense on March 2, 1995. The first count of the original indictment alleged that on or about November 17, 1994, appellant:

knowingly and intentionally possessed] a controlled substance analogue, namely, dextromethorphan and ephedrine, a substance which is intended in whole or in part for human consumption and which is specifically designed to produce an effect substantially similar to or greater than the effect of the controlled substance, to wit: 3,4 methylenedioxy methamphetamine in an amount of aggregate weight, including any adulterants and dilutants, of more than four hundred grams.

The primary offense was prosecuted under the provisions of section 481.123(b)(2) of the health and safety code, which were in effect in 1994. See Act of May 18, 1989, 71st Leg., R.S., ch. 678, § 1, 1989 Tex. Gen. Laws 2230, 2940 (Tex. Health & Safety Code Ann. § 481.123(b)(2)). 2 On December 5, 2001, appellant was rein-dicted while the original 1995 indictment was pending. The reindictment contained a tolling paragraph alleging that appellant had been indicted on March 2, 1995, for the same offense and that indictment was pending when the reindictment was returned. The third paragraph of the reindictment alleged a prior felony theft conviction on September 26, 1991, for enhancement of punishment.

On May 7, 2002, appellant waived trial by jury and entered a plea of “not guilty” to the primary offense, the only count in the reindictment. Appellant entered pleas of “true” to the tolling paragraph and to the allegations in the enhancement paragraph. The evidence was presented in the form of affidavits and stipulations after appellant waived the appearance, confrontation, and cross-examination of witnesses. In a sworn stipulation, appellant admitted that on November 17, 1994, he knowingly and intentionally possessed dextromethor-phan and ephedrine in an amount of more *273 than four hundred grams. Appellant also stipulated to the admission of the State’s exhibits. Among the exhibits offered were the offense report, and news articles from the Associated Press [printed in the Corpus Christi-Caller-Times ] and the Dallas Morning News concerning the increasing use by young people of high doses of dex-tromethorphan, a noncontrolled substance, which can produce the effects of the controlled substance known as “ecstasy.” Department of Public Safety Chemist Joel Budge stated in his affidavit that the 930 tablets submitted to him were dextrome-thorphan and ephedrine and were similar in appearance and designed to produce an effect that was substantially similar to 3,4 methylenedioxy methamphetamine, which is ecstasy, and were intended for human consumption. Dr. William Watson, of the University of Texas Health Science Center at San Antonio, described in his affidavit that the effects on the human body of a combination of dextromethorphan and ephedrine would be indistinguishable from the effect of ecstasy. Pharmacist David Zátopek detailed in his affidavit the effects of high doses of dextromethorphan and ephedrine, and that together they were being abused for their side effects. Hays County Narcotic Task Force Sergeant Chase Stapp swore in his affidavit that, based upon his experience, dextromethor-phan and ephedrine are packaged together and sold by drug dealers as ecstasy.

Appellant offered the affidavit of Max Courtney, a forensic chemist, who stated that dextromethorphan and ephedrine were non-eontrolled substances and sold to the public over the counter and often used as a cough suppressant. We observe that 3,4 methylenedioxy methamphetamine (ecstasy) was a controlled substance listed in Penalty Group 2 at the time of the charged offense. See Act of May 18, 1989, 71st Leg., R.S., ch. 678, § 1, 1989 Tex. Gen. Laws 2230, 2928-29 (Tex. Health <& Safety Code Ann. § 481.103(1), since amended).

DISCUSSION

Under “Brief of the Argument,” appellant presents his single point of error as follows: “The Statute making it an offense to possess a chemical analogue ‘specifically designed to produce an effect substantially similar to a controlled substance’ is vague as applied to appellant” (Emphasis added.) However, our review of the record reveals that appellant failed to raise the “as applied” issue at the trial court in any manner. The question first presented is whether appellant’s contention was preserved for review. See Tex. RApp. P. 33.1(a)(1). As a general rule, trial counsel must object or otherwise preserve error, even if it is “incurable” or “constitutional.” Cockrell v. State, 933 S.W.2d 73, 89 (Tex.Crim.App.1996). Without proper preservation, even constitutional error may be waived. See Wright v. State, 28 S.W.3d 526, 536 (Tex.Crim.App.2000). Questions, however, about the facial constitutionality of a statute upon which a defendant’s conviction is based should be addressed even when such issues are raised for the first time on appeal. See Holberg v. State, 38 S.W.3d 137, 139 n. 7 (Tex.Crim.App.2000); Rabb v. State, 730 S.W.2d 751, 752 (Tex.Crim.App.1987); Bryant v. State, 47 S.W.3d 80, 84 (Tex.App.-Waco 2001, pet. ref'd); 43A George E. Dix & Robert O. Dawson, Texas Practice: Criminal Practice and Procedure § 42.253 (2d ed. 2001).

By contrast, a contention that a statute is unconstitutional as applied to an accused because of vagueness and uncertainty must be asserted in the trial court or it is waived. See Curry v. State, 910 S.W.2d 490, 496 n. 2 (Tex.Crim.App.1995); Garcia v. State, 887 S.W.2d 846, 861 (Tex.Crim.App.1994); State v. West, 20 S.W.3d *274 867, 873 (Tex.App.-Dallas 2000, pet. ref'd); Sullivan v. State, 986 S.W.2d 708, 711 (Tex.App.-Dallas 1999, no pet.). In McGowan v. State, the rationale underlying the foregoing rules was explained. 938 S.W.2d 732, 736 (Tex.App.-Houston [14th Dist.] 1996), aff'd on other grounds, 975 S.W.2d 621 (Tex.Crim.App.1998). The McGowan holding has been analyzed in detail:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Michael Anthony Minor v. the State of Texas
Court of Appeals of Texas, 2025
Brian Scott Sharp v. the State of Texas
Court of Appeals of Texas, 2024
Michael Gonzalez v. the State of Texas
Court of Appeals of Texas, 2023
Gerardo Renee Barlow v. the State of Texas
Court of Appeals of Texas, 2023
Commonwealth, Aplt. v. Herman, J.
161 A.3d 194 (Supreme Court of Pennsylvania, 2017)
Commonwealth v. Herman
161 A.3d 194 (Supreme Court of Pennsylvania, 2017)
Hightower Obryant v. State
Court of Appeals of Texas, 2009
Adams v. State
222 S.W.3d 37 (Court of Appeals of Texas, 2007)
Curtis L. Adams v. State
Court of Appeals of Texas, 2005

Cite This Page — Counsel Stack

Bluebook (online)
106 S.W.3d 270, 2003 WL 1922371, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hooper-v-state-texapp-2003.